We are live on
!
Find out more
HI
Human Investing Portfolio holdings
AUM
$771M
1-Year Est. Return
18.84%
This Fund
S&P 500
This Quarter
Est. Return
-3.3%
1 Year Est. Return
+18.84%
3 Year Est. Return
+51.96%
5 Year Est. Return
+53.41%
10 Year Est. Return
–
AUM
$429M
AUM Growth
-$8.8M
(-2%)
Cap. Flow
+$6.8M
Cap. Flow
% of AUM
1.58%
Top 10 Holdings %
Top 10 Hldgs %
70.05%
Holding
103
New
4
Increased
31
Reduced
54
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.09M |
| 2 |
Vanguard ESG US Stock ETF
ESGV
|
+$1.54M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.11M |
| 4 |
Amgen
AMGN
|
+$511K |
| 5 |
Microsoft
MSFT
|
+$496K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$581K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$372K |
| 3 |
Apple
AAPL
|
+$358K |
| 4 |
Lamb Weston
LW
|
+$262K |
| 5 |
K
Kellanova
K
|
+$240K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4% |
| 2 | Healthcare | 2.96% |
| 3 | Consumer Discretionary | 2.35% |
| 4 | Consumer Staples | 0.79% |
| 5 | Communication Services | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Royal Caribbean
RCL
$86.5B
| – | – |
-2,092
| Closed | -$217K |
|
102
Schwab US Mid-Cap ETF
SCHM
$14.6B
| – | – |
-8,634
| Closed | -$204K |
|
103
ExxonMobil
XOM
$636B
| – | – |
-1,978
| Closed | -$212K |
|
Similar funds
WI
CCA
PGA
SC
PA
BPIM
TCM
PC
Human Investing's Q3 2023 Portfolio in Review
As of Q3 2023, Human Investing held 103 positions worth $429M, down 2% from $438M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Human Investing's Q3 2023 filing shows 4 new, 31 increased, 54 reduced and 8 closed positions. Its largest new stake was Thermo Fisher Scientific: 704 shares worth $356K. The largest sale was Merck, an estimated $581K.
By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 4.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Human Investing's largest Q3 2023 buy was Thermo Fisher Scientific: 704 shares worth $356K.
- Human Investing added most to Vanguard S&P 500 ETF in Q3 2023, an estimated $3.09M increase.
- Human Investing's biggest Q3 2023 reduction was Merck, cutting an estimated $581K.
- Human Investing fully exited Lamb Weston in Q3 2023, selling an estimated $262K.
- Human Investing's ten largest holdings make up 70% of its $429M portfolio in Q3 2023.
- Human Investing opened 4 new positions and closed 8 in Q3 2023.
- Human Investing's portfolio value fell 2% quarter-over-quarter to $429M.
Based on Human Investing's 13F filing for Q3 2023, filed 9 Nov 2023.